Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype

Claudio Carta, Francesca Pantaleoni, Gianfranco Bocchinfuso, Lorenzo Stella, Isabella Vasta, Anna Sarkozy, Cristina Digilio, Antonio Palleschi, Antonio Pizzuti, Paola Grammatico, Giuseppe Zampino, Bruno Dallapiccola, Bruce D. Gelb, Marco Tartaglia

Research output: Contribution to journalArticle

Abstract

Noonan syndrome (NS) is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart disease, and multiple skeletal and hematologic defects. NS is an autosomal dominant trait and is genetically heterogeneous. Gain of function of SHP-2, a protein tyrosine phosphatase that positively modulates RAS signaling, is observed in nearly 50% of affected individuals. Here, we report the identification of heterozygous KRAS gene mutations in two subjects exhibiting a severe NS phenotype with features overlapping those of cardiofaciocutaneous and Costello syndromes. Both mutations were de novo and affected exon 6, which encodes the C-terminal portion of KRAS isoform B but does not contribute to KRAS isoform A. Structural analysis indicated that both substitutions (Val152Gly and Asp153Val) perturb the conformation of the guanine ring-binding pocket of the protein, predicting an increase in the guanine diphosphate/guanine triphosphate (GTP) dissociation rate that would favor GTP binding to the KRASB isoform and bypass the requirement for a guanine nucleotide exchange factor.

Original languageEnglish
Pages (from-to)129-135
Number of pages7
JournalAmerican Journal of Human Genetics
Volume79
Issue number1
DOIs
Publication statusPublished - Jul 2006

Fingerprint

Noonan Syndrome
Germ-Line Mutation
Guanine
Missense Mutation
Protein Isoforms
Phenotype
Costello Syndrome
Non-Receptor Type 11 Protein Tyrosine Phosphatase
Guanine Nucleotide Exchange Factors
Mutation
Diphosphates
Exons
Heart Diseases
Carrier Proteins
Genes
triphosphoric acid

ASJC Scopus subject areas

  • Genetics

Cite this

Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. / Carta, Claudio; Pantaleoni, Francesca; Bocchinfuso, Gianfranco; Stella, Lorenzo; Vasta, Isabella; Sarkozy, Anna; Digilio, Cristina; Palleschi, Antonio; Pizzuti, Antonio; Grammatico, Paola; Zampino, Giuseppe; Dallapiccola, Bruno; Gelb, Bruce D.; Tartaglia, Marco.

In: American Journal of Human Genetics, Vol. 79, No. 1, 07.2006, p. 129-135.

Research output: Contribution to journalArticle

Carta, C, Pantaleoni, F, Bocchinfuso, G, Stella, L, Vasta, I, Sarkozy, A, Digilio, C, Palleschi, A, Pizzuti, A, Grammatico, P, Zampino, G, Dallapiccola, B, Gelb, BD & Tartaglia, M 2006, 'Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype', American Journal of Human Genetics, vol. 79, no. 1, pp. 129-135. https://doi.org/10.1086/504394
Carta, Claudio ; Pantaleoni, Francesca ; Bocchinfuso, Gianfranco ; Stella, Lorenzo ; Vasta, Isabella ; Sarkozy, Anna ; Digilio, Cristina ; Palleschi, Antonio ; Pizzuti, Antonio ; Grammatico, Paola ; Zampino, Giuseppe ; Dallapiccola, Bruno ; Gelb, Bruce D. ; Tartaglia, Marco. / Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. In: American Journal of Human Genetics. 2006 ; Vol. 79, No. 1. pp. 129-135.
@article{2b329d4366fc49a3ad5fe94ebd896bf2,
title = "Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype",
abstract = "Noonan syndrome (NS) is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart disease, and multiple skeletal and hematologic defects. NS is an autosomal dominant trait and is genetically heterogeneous. Gain of function of SHP-2, a protein tyrosine phosphatase that positively modulates RAS signaling, is observed in nearly 50{\%} of affected individuals. Here, we report the identification of heterozygous KRAS gene mutations in two subjects exhibiting a severe NS phenotype with features overlapping those of cardiofaciocutaneous and Costello syndromes. Both mutations were de novo and affected exon 6, which encodes the C-terminal portion of KRAS isoform B but does not contribute to KRAS isoform A. Structural analysis indicated that both substitutions (Val152Gly and Asp153Val) perturb the conformation of the guanine ring-binding pocket of the protein, predicting an increase in the guanine diphosphate/guanine triphosphate (GTP) dissociation rate that would favor GTP binding to the KRASB isoform and bypass the requirement for a guanine nucleotide exchange factor.",
author = "Claudio Carta and Francesca Pantaleoni and Gianfranco Bocchinfuso and Lorenzo Stella and Isabella Vasta and Anna Sarkozy and Cristina Digilio and Antonio Palleschi and Antonio Pizzuti and Paola Grammatico and Giuseppe Zampino and Bruno Dallapiccola and Gelb, {Bruce D.} and Marco Tartaglia",
year = "2006",
month = "7",
doi = "10.1086/504394",
language = "English",
volume = "79",
pages = "129--135",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype

AU - Carta, Claudio

AU - Pantaleoni, Francesca

AU - Bocchinfuso, Gianfranco

AU - Stella, Lorenzo

AU - Vasta, Isabella

AU - Sarkozy, Anna

AU - Digilio, Cristina

AU - Palleschi, Antonio

AU - Pizzuti, Antonio

AU - Grammatico, Paola

AU - Zampino, Giuseppe

AU - Dallapiccola, Bruno

AU - Gelb, Bruce D.

AU - Tartaglia, Marco

PY - 2006/7

Y1 - 2006/7

N2 - Noonan syndrome (NS) is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart disease, and multiple skeletal and hematologic defects. NS is an autosomal dominant trait and is genetically heterogeneous. Gain of function of SHP-2, a protein tyrosine phosphatase that positively modulates RAS signaling, is observed in nearly 50% of affected individuals. Here, we report the identification of heterozygous KRAS gene mutations in two subjects exhibiting a severe NS phenotype with features overlapping those of cardiofaciocutaneous and Costello syndromes. Both mutations were de novo and affected exon 6, which encodes the C-terminal portion of KRAS isoform B but does not contribute to KRAS isoform A. Structural analysis indicated that both substitutions (Val152Gly and Asp153Val) perturb the conformation of the guanine ring-binding pocket of the protein, predicting an increase in the guanine diphosphate/guanine triphosphate (GTP) dissociation rate that would favor GTP binding to the KRASB isoform and bypass the requirement for a guanine nucleotide exchange factor.

AB - Noonan syndrome (NS) is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart disease, and multiple skeletal and hematologic defects. NS is an autosomal dominant trait and is genetically heterogeneous. Gain of function of SHP-2, a protein tyrosine phosphatase that positively modulates RAS signaling, is observed in nearly 50% of affected individuals. Here, we report the identification of heterozygous KRAS gene mutations in two subjects exhibiting a severe NS phenotype with features overlapping those of cardiofaciocutaneous and Costello syndromes. Both mutations were de novo and affected exon 6, which encodes the C-terminal portion of KRAS isoform B but does not contribute to KRAS isoform A. Structural analysis indicated that both substitutions (Val152Gly and Asp153Val) perturb the conformation of the guanine ring-binding pocket of the protein, predicting an increase in the guanine diphosphate/guanine triphosphate (GTP) dissociation rate that would favor GTP binding to the KRASB isoform and bypass the requirement for a guanine nucleotide exchange factor.

UR - http://www.scopus.com/inward/record.url?scp=33745265268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745265268&partnerID=8YFLogxK

U2 - 10.1086/504394

DO - 10.1086/504394

M3 - Article

C2 - 16773572

AN - SCOPUS:33745265268

VL - 79

SP - 129

EP - 135

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -